RISPERDAL

Amid flurry of settlements, J&J resolves Risperdal claims

J&J has settled roughly 9,000 liability claims in the U.S. surrounding its antipsychotic drug Risperdal for $800 million.

Kevin Dunleavy Nov 1, 2021 10:45am

J&J scores as trial judge cuts $8B Risperdal verdict to $6.8M

Jan 21, 2020 10:39am

Appeals court upholds $70M Risperdal verdict against J&J

Nov 26, 2019 4:30pm

J&J's Risperdal caseload explodes with Pennsylvania ruling

Nov 21, 2019 10:42am

J&J, besieged by lawsuits, could be a steal for investors

Oct 11, 2019 10:38am

Jury hits J&J with $8B Risperdal verdict, but will it stand?

Oct 9, 2019 10:30am